Price Alert

ADMA Biologics Inc. (ADMA)

NASDAQ: ADMA · Real-Time Price · USD

15.61

0.29 (1.89%)

At close: Sep 26, 2025, 3:59 PM

15.62

0.06%

After-hours: Sep 26, 2025, 07:57 PM EDT

1.89% (1D)

Bid	15.27
Market Cap	3.73B
Revenue (ttm)	474.17M
Net Income (ttm)	208.93M
EPS (ttm)	0.85
PE Ratio (ttm)	18.36
Forward PE	17.21
Analyst	Strong Buy
Dividends	n/a

Ask	15.62
Volume	2,467,431
Avg. Volume (20D)	3,113,488
Open	15.39
Previous Close	15.32
Day's Range	15.38 - 15.62
52-Week Range	13.50 - 25.67
Beta	0.53
Ex-Dividend Date	n/a

About ADMA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ADMA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ADMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

ADMA Biologics Inc. is scheduled to release its earnings on Nov 6, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

-9.65%

ADMA Biologics shares are trading lower after the ... Unlock content with Pro Subscription

1 month ago

-2.22%

ADMA Biologics shares are trading lower after the company reported worse-than-expected Q2 revenue results and issued FY26 revenue guidance below estimates.

News

1 day ago · zacks.com

Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy...

3 days ago · zacks.com

Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors

In the latest trading session, Adma Biologics (ADMA) closed at $15.32, marking a -2.17% move from the previous day.

1 week ago · zacks.com

Adma Biologics (ADMA) Stock Dips While Market Gains: Key Facts

In the latest trading session, Adma Biologics (ADMA) closed at $15.91, marking a -1.55% move from the previous day.

1 week ago · zacks.com

Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note

Adma Biologics (ADMA) closed the most recent trading day at $15.3, moving 5.03% from the previous trading session.

2 weeks ago · zacks.com

Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

3 weeks ago · seekingalpha.com

ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside

ADMA Biologics' earnings are surging due to higher plasma yield and a profitable shift toward premium IG brands, boosting margins. FDA approval of yield-enhancement technology increases finished IG ou...

1 month ago · seekingalpha.com

ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

ADMA's growth remains centered on Asceniv, Bivigam, and NABI-HB. These are its main value drivers today. ADMA Biologics' recent Q2 report showed that the company is working on enhancing its plasma yie...

1 month ago · seekingalpha.com

ADMA Biologics: A Better Quarter Than Headline Numbers

ADMA Biologics experienced a significant stock pullback on Thursday after Q2 results, presenting a potential buying opportunity for investors. The company now operates 10 plasma collection centers and...